Immunohistochemical investigation of mid-dermal elastolysis with a history of erythema

American Journal of Dermatopathology

Volumn 30, Issue 5, 2008, Pages 477-480

  Suda, Takane ^a   Hara, H ^a   Yoshitake, M ^a   Ohbayashi, T ^b   Nakamura, T ^b   Terui, T ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Fibulin 5; Mid dermal elastolysis; MMP 9

Indexed keywords

ANTIHISTAMINIC AGENT; CHLORDANE; CORTICOSTEROID; DAPSONE; ELASTIN; FIBULIN 5; GELATINASE B; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; FBLN5 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DERMIS; ELASTOLYSIS; ERYTHEMA; FEMALE; GIANT CELL; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MID DERMAL ELASTOLYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; WRINKLE; ELASTIC TISSUE; ELASTICITY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DERMIS; ELASTIC TISSUE; ELASTICITY; ELASTIN; ERYTHEMA; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HISTIOCYTES; HUMANS; MATRIX METALLOPROTEINASE 9;

EID: 58149296054     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318176b874     Document Type: Article

References (14)

1. Shelley WB, Wood MG. Wrinkling due to idiopathic loss of mid-dermal elastic tissue. Br J Dermatol. 1977;97:441-445.
2. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci. 2002; 115:2817-2828.
3. Ramirez F, Sakai LY, Dietz HC, et al. Fibrillin microfibrils: multipurpose extracellular networks in organismal physiology. Physiol Genomics. 2004; 19:151-154.
4. Nakamura T, Lozana PR, Ikeda Y, et al. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature. 2002;415:171-175.
5. Yanagisawa H, Davis EC, Starcher BC, et al. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature. 2002;415:168-171.
6. Loeys B, van Maldergem L, Mortier G, et al. Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet. 2002;11:2113-2118.
7. Grossin M, Maghraoui S, Crickx B, et al. The spectrum of dermal elastolysis. J Am Acad Dermatol. 1993;29:506-507.
8. Betti R, Urbani CE, Lodi A, et al. Noninflammatory focal dermal elastolysis. J Am Acad Dermatol. 1992;27:113-115.
9. Brod BA, Rabkin M, Rhodes AR, et al. Mid-dermal elastolysis with inflammation. J Am Acad Dermatol. 1992;26:882-884.
10. Patroi I, Annessi G, Girolomoni G. Mid-dermal elastolysis: a clinical, histologic, and immunohistochemical study of 11 patients. J Am Acad Dermatol. 2003;48:846-851.
11. Venencie PY, Bonnefoy A, Gogly B, et al. Increased expression of gelatinases A and B by skin explants from patients with anetoderma. Br J Dermatol. 1997;137:517-525.
12. Vaalamo M, Kariniemi AL, Shapiro SD, et al. Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. J Invest Dermatol. 1999;112:499-505.
13. Kadoya K, Sasaki T, Kostka G, et al. Fibulin-5 deposition in human skin: decrease with ageing and ultraviolet B exposure and increase in solar elastosis. Br J Dermatol. 2005;153:607-612.
14. Nakamura T, Ruiz-Lozano P, Lindner V, et al. DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J Biol Chem. 1999;274:22476-22483.